Angiotensin II vs Urotensin-II — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Angiotensin II is the principal effector peptide of the renin-angiotensin-aldosterone system (RAAS), a master regulator of blood pressure, fluid balance, and cardiovascular function. Generated by sequential cleavage of angiotensinogen by renin (producing Ang I) then by angiotensi...
Calculate Angiotensin II dose →Human Urotensin-II (U-II) is an 11-amino acid cyclic peptide and the most potent mammalian vasoconstrictor identified to date - approximately 10 to 20 times more potent than endothelin-1 in isolated vascular preparations. Originally characterized in fish urophysis (caudal neurose...
Calculate Urotensin-II dose →| Parameter | Angiotensin II | Urotensin-II |
|---|---|---|
| Category | Vasoactive Peptide | Vasoactive Peptide |
| Research | Clinical | Active Research |
| Half-Life | 30 seconds - 2 minutes (plasma) | ~30 minutes (plasma) |
| Typical Dose | 20-40 ng/kg/min (vasopressor) | 0.01-1 nmol/kg/min IV (animal); picomolar concentrations produce vasoconstriction |
| Frequency | Continuous infusion in clinical use | Acute infusion |
| Route | Intravenous (continuous infusion) | IV infusion (research/clinical studies) |
| FDA Status | Approved (Giapreza, vasodilatory shock) | Research compound; UT receptor antagonists in clinical trials |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.